Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10 Genitourinary 3 Thoracic 1 Plasma cell 1 Gynecologic 1 CNS 1 Breast 1

Conditions

Multiple Myeloma 463 Neoplasms, Plasma Cell 81 Lymphoma 75 Leukemia 51 Lymphoma, Non-Hodgkin 49 Leukemia, Lymphocytic, Chronic, B-Cell 45 Myelodysplastic Syndromes 43 Immunoglobulin Light-chain Amyloidosis 42 Leukemia, Myeloid, Acute 39 Hodgkin Disease 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Neoplasms 32 Hematologic Neoplasms 31 Breast Neoplasms 31 Myeloproliferative Disorders 29 Lymphoma, Large B-Cell, Diffuse 29 Lymphoma, Follicular 29 Monoclonal Gammopathy of Undetermined Significance 28 Smoldering Multiple Myeloma 25 Lymphoma, Mantle-Cell 25 Lymphoma, B-Cell, Marginal Zone 24 Recurrence 23 Burkitt Lymphoma 21 Amyloidosis 21 Prostatic Neoplasms 20 Lymphoma, T-Cell, Cutaneous 20 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19 Waldenstrom Macroglobulinemia 18 Sezary Syndrome 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Frailty × Plasma cell × Clear all

NCT06099912 2026-02-12

DynaFiT

The First Hospital of Jilin University

Frailty, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡